| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Kelly Timothy Edwin is a Chief Financial Officer at Praxis Precision Medicines, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $10.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2023 | PRAX Praxis Precision Medicines, Inc. | Chief Financial Officer | Buy | 8,000 | $0.87 | $6,997.60 | +20.8% | +40.7% | +339.5% | |
| Jun 9, 2022 | PRAX Praxis Precision Medicines, Inc. | Chief Financial Officer | Buy | 10,000 | $1.77 | $17,650.00 | +32.8% | +81.1% | -43.5% | |
| Aug 31, 2021 | PRAX Praxis Precision Medicines, Inc. | Chief Financial Officer | Buy | 3,905 | $19.48 | $76,069.40 | New | -14.0% | -84.3% |